Review Current status of poliovirus infections.[Clin Microbiol Rev. 1996]

Melnick JL

Clin Microbiol Rev. 1996 Jul; 9(3):293-300.
Poliomyelitis virus in urban sewage in epidemic and in nonepidemic times.[Am J Hyg. 1947]

MELNICK JL

Am J Hyg. 1947 Mar; 45(2):240-53.
My role in the discovery and classification of the enteroviruses.[Annu Rev Microbiol. 1996]

Melnick JL

Annu Rev Microbiol. 1996; 50():1-24.

Review Francis field trial of inactivated poliomyelitis vaccine: background and lessons for today.[Epidemiol Rev. 1999]

Monto AS

Epidemiol Rev. 1999; 21(1):7-23.
Review Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease.[Clin Infect Dis. 1992]

Strebel PM, Sutter RW, Cochi SL, Biellik RJ, Brink EW, Kew OM, Pallansch MA, Orenstein WA, Hinman AR

Clin Infect Dis. 1992 Feb; 14(2):568-79.
Inactivated poliovirus vaccine: current production methods and new developments.[Rev Infect Dis. 1984]

van Wezel AL, van Steenis G, van der Marel P, Osterhaus AD

Rev Infect Dis. 1984 May-Jun; 6 Suppl 2():S335-40.
Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier.[Rev Infect Dis. 1984]

Montagnon BJ, Fanget B, Vincent-Falquet JC

Rev Infect Dis. 1984 May-Jun; 6 Suppl 2():S341-4.
Improved inactivated poliovirus vaccine: an update.[Pediatr Infect Dis. 1986]

Bernier RH

Pediatr Infect Dis. 1986 May-Jun; 5(3):289-92.
Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark.[Rev Infect Dis. 1984]

von Magnus H, Petersen I

Rev Infect Dis. 1984 May-Jun; 6 Suppl 2():S471-4.

Progress toward global eradication of poliomyelitis, 1988-1993.[MMWR Morb Mortal Wkly Rep. 1994]

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1994 Jul 15; 43(27):499-503.
Characterization of the RDC1 gene which encodes the canine homolog of a proposed human VIP receptor. Expression does not correlate with an increase in VIP binding sites.[FEBS Lett. 1992]

Cook JS, Wolsing DH, Lameh J, Olson CA, Correa PE, Sadee W, Blumenthal EM, Rosenbaum JS

FEBS Lett. 1992 Mar 30; 300(2):149-52.

Landmark article Aug 6, 1960: Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. By Albert B. Sabin, Manuel Ramos-Alvarez, José Alvarez-Amezquita, William Pelon, Richard H. Michaels, Ilya Spigland, Meinrad A. Koch, Joan M. Barnes, and Johng S. Rhim.[JAMA. 1984]

Sabin AB, Ramos-Alvarez M, Alvarez-Amezquita J, Pelon W, Michaels RH, Spigland I, Koch MA, Barnes JM, Rhim JS

JAMA. 1984 Jun 8; 251(22):2988-93.
Landmark perspective: Mass vaccination against polio.[JAMA. 1984]

Hinman AR

JAMA. 1984 Jun 8; 251(22):2994-6.
Russian contribution to OPV.[Biologicals. 1993]

Agol VI, Drozdov SG

Biologicals. 1993 Dec; 21(4):321-5.

Randomised trial of alternative formulations of oral poliovaccine in Brazil.[Lancet. 1988]

Patriarca PA, Laender F, Palmeira G, Oliveira MJ, Lima Filho J, Dantes MC, Cordeiro MT, Risi JB Jr, Orenstein WA

Lancet. 1988 Feb 27; 1(8583):429-33.
Expanded programme on immunization. Global Advisory Group--Part II.[Wkly Epidemiol Rec. 1991]

Wkly Epidemiol Rec. 1991 Jan 18; 66(3):9-12.

Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease.[Arch Pediatr Adolesc Med. 1994]

Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL

Arch Pediatr Adolesc Med. 1994 May; 148(5):479-85.

Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection.[Am J Epidemiol. 1994]

Strebel PM, Aubert-Combiescu A, Ion-Nedelcu N, Biberi-Moroeanu S, Combiescu M, Sutter RW, Kew OM, Pallansch MA, Patriarca PA, Cochi SL

Am J Epidemiol. 1994 Dec 15; 140(12):1111-24.

The work of the WHO Consultative Group on Poliomyelitis Vaccines.[Bull World Health Organ. 1988]

Cockburn WC

Bull World Health Organ. 1988; 66(2):143-54.
Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis.[N Engl J Med. 1995]

Strebel PM, Ion-Nedelcu N, Baughman AL, Sutter RW, Cochi SL

N Engl J Med. 1995 Feb 23; 332(8):500-6.
Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992-1994.[J Infect Dis. 1997]

Ion-Nedelcu N, Strebel PM, Toma F, Biberi-Moroeanu S, Combiescu M, Persu A, Aubert-Combiescu A, Plotkin SA, Sutter RW

J Infect Dis. 1997 Feb; 175 Suppl 1():S241-6.
The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.[Roum Arch Microbiol Immunol. 2007]

Băicuş A, Persu A, Combiescu M, Aubert-Combiescu A

Roum Arch Microbiol Immunol. 2007 Jan-Jun; 66(1-2):44-50.
Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania.[Arch Virol. 2007]

Combiescu M, Guillot S, Persu A, Baicus A, Pitigoi D, Balanant J, Oprisan G, Crainic R, Delpeyroux F, Aubert-Combiescu A

Arch Virol. 2007; 152(4):727-38.
The frequency and biodiversity of poliovirus and non-polio enterovirus strains isolated from healthy children living in a limited area in Romania.[Arch Virol. 2011]

Baicus A, Persu A, Dinu S, Joffret ML, Delpeyroux F, Oprisan G

Arch Virol. 2011 Apr; 156(4):701-6.

Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child.[Virus Res. 2007]

Adu F, Iber J, Bukbuk D, Gumede N, Yang SJ, Jorba J, Campagnoli R, Sule WF, Yang CF, Burns C, Pallansch M, Harry T, Kew O

Virus Res. 2007 Jul; 127(1):17-25.
Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study.[Lancet. 2007]

Grassly NC, Wenger J, Durrani S, Bahl S, Deshpande JM, Sutter RW, Heymann DL, Aylward RB

Lancet. 2007 Apr 21; 369(9570):1356-1362.
Progress toward interruption of wild poliovirus transmission--worldwide, 2008.[MMWR Morb Mortal Wkly Rep. 2009]

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Apr 3; 58(12):308-12.
Outbreak of poliomyelitis in Tajikistan in 2010: risk for importation and impact on polio surveillance in Europe?[Euro Surveill. 2010]

World Health Organization Country Office Tajikistan., WHO Regional Office for Europe., European Centre for Disease Prevention and Control.

Euro Surveill. 2010 Apr 29; 15(17):.
Update on vaccine-derived polioviruses.[MMWR Morb Mortal Wkly Rep. 2006]

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2006 Oct 13; 55(40):1093-7.
Fractional doses of inactivated poliovirus vaccine in Oman.[N Engl J Med. 2010]

Mohammed AJ, AlAwaidy S, Bawikar S, Kurup PJ, Elamir E, Shaban MM, Sharif SM, van der Avoort HG, Pallansch MA, Malankar P, Burton A, Sreevatsava M, Sutter RW

N Engl J Med. 2010 Jun 24; 362(25):2351-9.
Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba.[J Infect Dis. 2010]

Resik S, Tejeda A, Lago PM, Diaz M, Carmenates A, Sarmiento L, Alemañi N, Galindo B, Burton A, Friede M, Landaverde M, Sutter RW

J Infect Dis. 2010 May 1; 201(9):1344-52.
Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions.[Vaccine. 2011]

Baldwin SL, Fox CB, Pallansch MA, Coler RN, Reed SG, Friede M

Vaccine. 2011 Jan 17; 29(4):644-9.
Technology transfer of Sabin-IPV to new developing country markets.[Biologicals. 2006]

Kreeftenberg H, van der Velden T, Kersten G, van der Heuvel N, de Bruijn M

Biologicals. 2006 Jun; 34(2):155-8.
Development of inactivated poliovirus vaccine derived from Sabin strains.[Biologicals. 2006]

Simizu B, Abe S, Yamamoto H, Tano Y, Ota Y, Miyazawa M, Horie H, Satoh K, Wakabayashi K

Biologicals. 2006 Jun; 34(2):151-4.
The polio endgame.[N Engl J Med. 2011]

Aylward B, Yamada T

N Engl J Med. 2011 Jun 16; 364(24):2273-5.

Save items

Similar articles in PubMed

Cited by other articles in PMC

Links

Recent Activity